CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in R...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2011-01-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Online Access: | https://pf.spr-journal.ru/jour/article/view/742 |
id |
doaj-7d1a0e97d17449ddbc8c18256c02b007 |
---|---|
record_format |
Article |
spelling |
doaj-7d1a0e97d17449ddbc8c18256c02b0072020-11-25T01:58:32ZengPaediatrician Publishers, LLCPediatričeskaâ Farmakologiâ1727-57762500-30892011-01-01811721737CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTIONE.V. Uvarova0Z.Kh. Kumykova1V.I. Kulakov Federal State Institute Research Centre of Obstetrics, Gynecology and Perinatology of Russia’s Agency of Healthcare and Social DevelopmentV.I. Kulakov Federal State Institute Research Centre of Obstetrics, Gynecology and Perinatology of Russia’s Agency of Healthcare and Social DevelopmentThe article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in Russia, have been created and are successfully used for this purpose. The authors believe that the best results may be achieved by combining screening examination programmes with universal reasonable administration of scheduled voluntary vaccination of Russia’s population.Key words: human papilloma virus, HPV infection, cervical cancer, malignancies, prevention, vaccination.https://pf.spr-journal.ru/jour/article/view/742 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
E.V. Uvarova Z.Kh. Kumykova |
spellingShingle |
E.V. Uvarova Z.Kh. Kumykova CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION Pediatričeskaâ Farmakologiâ |
author_facet |
E.V. Uvarova Z.Kh. Kumykova |
author_sort |
E.V. Uvarova |
title |
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION |
title_short |
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION |
title_full |
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION |
title_fullStr |
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION |
title_full_unstemmed |
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION |
title_sort |
critical issues of papilloma virus infection prevention |
publisher |
Paediatrician Publishers, LLC |
series |
Pediatričeskaâ Farmakologiâ |
issn |
1727-5776 2500-3089 |
publishDate |
2011-01-01 |
description |
The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in Russia, have been created and are successfully used for this purpose. The authors believe that the best results may be achieved by combining screening examination programmes with universal reasonable administration of scheduled voluntary vaccination of Russia’s population.Key words: human papilloma virus, HPV infection, cervical cancer, malignancies, prevention, vaccination. |
url |
https://pf.spr-journal.ru/jour/article/view/742 |
work_keys_str_mv |
AT evuvarova criticalissuesofpapillomavirusinfectionprevention AT zkhkumykova criticalissuesofpapillomavirusinfectionprevention |
_version_ |
1724969037669072896 |